About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,073 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,073 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 801-820 of 13,073 trials

CompletedExact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingThe objective of this study is to confirm the sensitivity and specificity of a stool DNA test for detection of colorectal cancer and pre-cancer.NCT01600209·Tucson, Arizona and 12 others TerminatedA Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut SyndromeThe main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in children and adults with Dravet Syndrome (DS) or…NCT05163314·Phoenix, Arizona and 115 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedStudy of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-RespondersThe purpose of this study is to determine if the combination treatment of CTS-1027, pegylated interferon and ribavirin can improve the response rates in HCV patients who did not…NCT01051921·La Jolla, California and 14 others

CompletedDasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib MesylateThe purpose of this study is to see what effect an investigational drug (BMS-354825) has on subjects who are currently in the myeloid blast phase of chronic myeloid leukemia (CML)…NCT00101816·Birmingham, Alabama and 61 others

CompletedComparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate CancerThis study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer.NCT01326286·Los Angeles, California and 4 others

CompletedEfficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual SchizophreniaThe objectives of this 12-week study are to evaluate the efficacy, safety, and tolerability of AVP-786 as an adjunctive treatment compared with placebo in patients with residual…NCT02477670·Cerritos, California and 16 others

CompletedEfficacy Study of EVT 201 to Treat InsomniaThe purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other…NCT00380003·St. Petersburg, Florida and 4 others

CompletedImmune Enhancement for Immunological Non-responders to ARTThe purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV.NCT01806870·Atlanta, Georgia and 1 other

TerminatedaHUS Observational Long Term Follow-UpThere is growing but limited information on the long term clinical status of aHUS patients who have previously received or are continuing to receive treatment with eculizumab.NCT01522170·Atlanta, Georgia and 55 others

TerminatedAn Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerThis study will collect real-world clinical and patient reported outcomes (PRO) and diary data from eligible patients with documented Human Epidermal Growth Factor Receptor 2…NCT05592483·Mobile, Alabama and 124 others

Enrolling by invitationA Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell ProductThe primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.NCT06701201·Denver, Colorado and 6 others

CompletedSafety and Efficacy Study of Treatment of Pathological Fractures in HumerusThis study will collect safety and performance data of the Photodynamic Bone Stabilization System (PBSS) when used for the treatment of fractures of the humerus secondary to…NCT02338492·Redwood City, California and 12 others

TerminatedPhase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusThis study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.NCT00208936·Atlanta, Georgia

CompletedOpen-label Study of Dupilumab in Patients With Atopic DermatitisThe primary objective is to assess the long-term safety of dupilumab administered in adult participants with atopic dermatitis (AD).NCT01949311·Anniston, Alabama and 431 others

CompletedDocetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung CancerThis randomized phase I/II trial studies the side effects and best dose of fibroblast growth factor receptor (FGFR) inhibitor AZD4547 when given with docetaxel and to see how well…NCT01824901·Atlanta, Georgia and 4 others

RecruitingA Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerThe purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in…NCT06119581·Huntsville, Alabama and 414 others

CompletedPF-06669571 In Subjects With Idiopathic Parkinson's DiseaseThis study is designed to assess safety, tolerability and pharmacokinetic data for multiple doses of PF-06669571 in subjects with idiopathic Parkinson's disease.NCT02565628·New Haven, Connecticut and 8 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDThe purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with…NCT00206167·Birmingham, Alabama and 215 others

TerminatedSafety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple MyelomaThis is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in combination with other…NCT04855136·Birmingham, Alabama and 16 others

CompletedPhase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)The purpose of this study is to determine whether ornithine phenylacetate can speed recovery from an acute hepatic encephalopathy episode requiring hospitalization in cirrhotic…NCT01966419·Phoenix, Arizona and 130 others

PreviousPage 41 of 654Next

in Atlanta

Heart Diseasein Atlanta